Skip to content

Selecting optimized method for ovulation induction

Clomiphen citrate versus metformin as first line approach for the treatment of anovulation in infertile patients with Polycystic Ovarian Syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201106236871N1
Enrollment
104
Registered
2011-11-09
Start date
2010-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female infertility

Interventions

Intervention 1: First group: Metformin will be started at 500mg daily and increased to maximum dose of 1500 mg daily during 3 weeks. Intervention 2: Second group: clomiphene citrate 100 mg orally for
Treatment - Drugs
First group: Metformin will be started at 500mg daily and increased to maximum dose of 1500 mg daily during 3 weeks.
Second group: clomiphene citrate 100 mg orally for 5 days since 3rd day of menstruation cycle.

Sponsors

Vice chancellor for research, Bushehr University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Infertile anovulating PCO women in reproductive age of 18-30 and BMI of 19-25. Exclusion criteria: Any abnormality in thyroid and prolactin tests; structural abnormalities of uterus and tubes; metabolic disorders; cardiac and liver disease; cushing disease and OCP users.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pregnancy. Timepoint: 14 days after ovulation. Method of measurement: ßhCG Test.;Adequate follicle (16-22mm). Timepoint: 13th - 14th day of mensturation cycle. Method of measurement: Vaginal sonography.;Serum progestron level. Timepoint: The 21th day of mensturation cycle. Method of measurement: Biochemical methods for measuring progestron titer.;Alive fetus. Timepoint: The 7th week of pregnancy. Method of measurement: Vaginal sonography.

Secondary

MeasureTime frame
Multiple pregnancy. Timepoint: 7th week. Method of measurement: Ultasonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr shahnaz Ahmadi

Bushehr University of Medical Sciences, Medical Faculty

ahmadishahnaz2005@yahoo.com+98 77 1252 4044

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026